West Virginia issues drinking water advisory for pregnant women in wake of chemical spill

Richard Denison, Ph.D., is a Senior Scientist.

Shortly after 8pm this evening, the West Virginia Department of Health issued a “Water Advisory for Pregnant Women” in connection with last Thursday’s chemical spill.  The news was first reported by Ken Ward, Jr. and David Gutman in the Charleston Gazette.

The Advisory states:

The West Virginia Bureau for Public Health advises, after consultation with the U.S. Centers for Disease Control and Prevention (CDC) this evening, that the CDC recommends—out of an abundance of caution—that pregnant women drink bottled water until there are no longer detectable levels of MCHM in the water distribution system. However, the CDC re-affirmed previous advice that it does not anticipate any adverse health effects from levels less than 1 ppm.

Guidance from the CDC is attached.

Two other documents are available:

It is unclear what prompted tonight’s issuance of the Advisory, which comes six days into the spill.  However, one clue may be in the CDC letter, which states:

Since making the initial calculations, scientists have obtained additional animal studies about MCHM.  These are currently being reviewed.  At this time, the scientists continue to recommend 1 ppm as a protective level to prevent adverse health effects.  However, due to limited availability of data, and out of an abundance of caution, you may wish to consider an alternative drinking water source for pregnant women until the chemical is at non-detectable levels in the water distribution system. (emphasis added)

It appears the new information prompted the CDC recommendation that West Virginia consider advising pregnant women to avoid drinking the water, which raises the question as to whether the new animal studies suggest a potential for developmental toxicity or a related effect.

It should be noted that the answer to the first question in the FAQ document states: “There are no known studies showing harm to the fetus as a result of consuming water with MCHM levels below 1 ppm.”

Clearly something prompted the issuance of the advisory.  I hope we’ll learn more shortly.

Questions have already been raised on this blog about the lack of data on this chemical and the methodology used by government officials to calculate the 1 ppm level.  This new development, however, I believe lends even greater weight to the need for immediate public release of both all available studies and the methodology.

 

This entry was posted in Environment, Health Policy, Regulation and tagged , . Bookmark the permalink. Both comments and trackbacks are currently closed.

One Comment

  1. Kirkmurphy
    Posted January 16, 2014 at 1:58 am | Permalink

    Dr. Denison, profound thanks to you and EDF for spotlighting the crucial question of whether the crude MCHM leak can cause developmental toxicity.

    For three days I been asking the CDC on twitter about a core aspect of this potential risk: do the crude MCHM tank chemicals or their breakdown (via human metabolism or the external environment) products act as endocrine disruptors? Given that some ED's are known to be active at parts per *trillion* – over 1,000 times less than the 1 ppm level – no one can say if the affected water is safe to drink until the CDC fully and completely releases experiential data showing no endocrine disruption.

  • About this blog

    Science, health, and business experts at Environmental Defense Fund comment on chemical and nanotechnology issues of the day.

    Our work: Chemicals

  • Categories

  • Get blog posts by email

    Subscribe via RSS

  • Filter posts by tags

    • aggregate exposure (10)
    • Alternatives assessment (3)
    • American Chemistry Council (ACC) (55)
    • arsenic (3)
    • asthma (3)
    • Australia (1)
    • biomonitoring (9)
    • bipartisan (6)
    • bisphenol A (19)
    • BP Oil Disaster (18)
    • California (1)
    • Canada (7)
    • carbon nanotubes (24)
    • carcinogen (22)
    • Carcinogenic Mutagenic or Toxic for Reproduction (CMR) (12)
    • CDC (6)
    • Chemical Assessment and Management Program (ChAMP) (13)
    • chemical identity (30)
    • chemical testing (1)
    • Chemicals in Commerce Act (3)
    • Chicago Tribune (6)
    • children's safety (23)
    • China (10)
    • computational toxicology (11)
    • Confidential Business Information (CBI) (52)
    • conflict of interest (4)
    • consumer products (48)
    • Consumer Specialty Products Association (CSPA) (4)
    • contamination (4)
    • cumulative exposure (4)
    • data requirements (46)
    • dermal exposure (1)
    • diabetes (4)
    • DNA methylation (4)
    • DuPont (11)
    • endocrine disruption (28)
    • epigenetics (4)
    • exposure and hazard (49)
    • FDA (8)
    • flame retardants (20)
    • formaldehyde (15)
    • front group (13)
    • general interest (22)
    • Globally Harmonized System (GHS) (5)
    • Government Accountability Office (5)
    • hazard (6)
    • High Production Volume (HPV) (22)
    • in vitro (14)
    • in vivo (11)
    • industry tactics (41)
    • informed substitution (1)
    • inhalation (18)
    • IUR/CDR (27)
    • Japan (3)
    • lead (6)
    • markets (1)
    • mercury (4)
    • methylmercury (2)
    • microbiome (3)
    • nanosilver (6)
    • National Academy of Sciences (NAS) (20)
    • National Institute for Occupational Safety and Health (NIOSH) (7)
    • National Institute of Environmental Health Sciences (NIEHS) (5)
    • National Nanotechnology Initiative (NNI) (7)
    • National Toxicology Program (1)
    • obesity (6)
    • Occupational Safety and Health Administration (OSHA) (3)
    • Office of Information and Regulatory Affairs (OIRA) (4)
    • Office of Management and Budget (OMB) (16)
    • Office of Pollution Prevention and Toxics (OPPT) (3)
    • oil dispersant (18)
    • PBDEs (16)
    • Persistent Bioaccumulative and Toxic (PBT) (22)
    • pesticides (7)
    • phthalates (17)
    • polycyclic aromatic hydrocarbons (PAH) (5)
    • prenatal (6)
    • prioritization (35)
    • report on carcinogens (1)
    • revised CSIA (3)
    • risk assessment (69)
    • Safe Chemicals Act (24)
    • Safer Chemicals Healthy Families (33)
    • Significant New Use Rule (SNUR) (20)
    • Small business (1)
    • South Korea (4)
    • styrene (6)
    • Substances of Very High Concern (SVHC) (15)
    • systematic review (1)
    • test rule (17)
    • tributyltin (3)
    • trichloroethylene (TCE) (3)
    • Turkey (3)
    • U.S. states (14)
    • vulnerable populations (1)
    • Walmart (2)
    • worker safety (23)
    • WV chemical spill (11)
  • Archives

Your voice matters

Get urgent news about environmental issues, and find out when your voice can make a difference.

Read our privacy policy.